Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
about
A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cellsAutophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceUnraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review).SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathwayFactors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer.New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs.Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer.Cytokine networking of innate immunity cells: a potential target of therapy.Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer.Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics.
P2860
Q35338435-ABD731B2-5017-4B6C-B433-987F34EE67B3Q35500311-43BCE79B-6770-45B5-B8B2-5AFE5B312D8CQ36250585-78901020-D508-422E-9D17-44C020CE32D3Q37567784-22D59459-680A-4E6C-9922-083B877C2599Q37680287-7CC3C9C6-DDA1-4FB1-9265-3DD96D4256A1Q37698439-505041A1-88AA-4593-AA03-1E9F3F4D8D85Q37724947-61F40E12-1470-4A03-B0C6-FAADAA5C7EB3Q38167808-D9584F6F-72FB-4E80-9088-36B2A169CD10Q38180799-94A101EB-57AD-436A-9FC0-AC08A32FCC49Q38194591-9C0D5E8E-83B7-4DEA-B750-9AF9B60D01A3Q38219688-2690418F-FF12-4417-BF7B-F24E702B6AC8Q38264440-C74F8498-70ED-41D7-A55A-CECCD7CB117FQ39139907-4521A3F5-BCAF-428A-BCF2-93252D2D3FD9
P2860
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
@en
type
label
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
@en
prefLabel
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
@en
P2093
P2860
P50
P356
P1476
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
@en
P2093
Agnese Savini
Azzurra Onofri
Chiara Pellei
Chiara Pierantoni
Francesca Morgese
Mariagrazia De Lisa
Miriam Caramanti
Paola Mazzanti
Silvia Pagliaretta
Zelmira Ballatore
P2860
P304
P356
10.2147/OTT.S28155
P407
P577
2013-05-21T00:00:00Z